## **Core Concept**
The question tests the understanding of diagnostic modalities for breast cancer, specifically their ability to differentiate between ductal carcinoma in situ (DCIS or 'in situ' breast cancer) and invasive breast cancer. DCIS is a non-invasive condition where cancer cells are confined within the milk ducts, whereas invasive breast cancer involves the spread of cancer cells into surrounding breast tissue.

## **Why the Correct Answer is Right**
Mammography is a primary imaging technique used for breast cancer screening. It can detect calcifications and masses suggestive of cancer but often cannot reliably differentiate between DCIS and invasive cancer. DCIS may appear as microcalcifications on mammography without a distinct mass, but the presence of microcalcifications alone does not distinguish it from invasive cancer.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Ultrasound can help differentiate between cystic and solid lesions and may provide clues about the nature of a breast lesion, including suggesting invasion. However, it might not always reliably differentiate between in situ and invasive cancer.
* **Option B:** MRI can often distinguish between in situ and invasive cancer due to its ability to provide detailed images of breast tissue and assess the extent of disease. It can show the morphology and kinetics of lesions.
* **Option C:** (Assuming this is a hypothetical or specific type of advanced imaging) Without specifics, it's hard to evaluate, but generally, advanced imaging techniques or biopsies provide more detailed information about the invasiveness of cancer.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that while mammography is crucial for detecting breast abnormalities, its limitation in differentiating between DCIS and invasive cancer highlights the importance of biopsy (tissue sampling) for definitive diagnosis. Biopsy can directly assess the invasiveness of cancer cells.

## **Correct Answer:** .